Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter

Showing results (31-40 of 505) with videos related to

Pageof 51
Sort By:
Journal of Cancer Research and Clinical Oncology|January 31, 2018
Patients' and hematologists' concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemiaQian Jiang, Lu Yu, Robert Peter Gale
Mediterranean Journal of Hematology and Infectious Diseases|May 19, 2021
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple MyelomaMonia Marchetti, Robert Peter Gale, Giovanni Barosi
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|March 8, 2022
The application of arterio-venous ratio (AVR) cut-off values in clinic to stratify cardiovascular risk in patientsChristian French, Robert Peter Cubbidge, Rebekka Heitmar
Acta Haematologica|July 24, 2025
Beyond CAR-T: The Rise of CAR-NK/T Cells for Haematological CancerMohammadamin Noorafrooz, Robert Peter Gale, Mohadese Dashtkoohi
Bone Marrow Transplantation|February 25, 2018
The big freeze may be over: a contracting universe for cryopreservation?Robert Peter Gale, Guillermo J Ruiz-Argüelles
Leukemia Research|January 18, 2003
Modeling minimal residual disease (MRD)-testingAnna Butturini, John Klein, Robert Peter Gale
Journal of Clinical Medicine|July 2, 2021
Will New Drugs Replace Transplants for Chronic Lymphocytic Leukaemia?Shenmiao Yang, Xiaojun Huang, Robert Peter Gale
Journal of Hematology & Oncology|December 16, 2014
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemiaBing Li, Robert Peter Gale, Zhijian Xiao
Leukemia|March 4, 2023
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectivesGiovanni Barosi, Vittorio Rosti, Robert Peter Gale
Journal of Nanoscience and Nanotechnology|May 5, 2015
Synthesis and characterization of alkyl ester functionalized multiwall carbon nanotubesFabio Faraguna, Robert Peter, Vesna Volovšek, et al.
Pageof 51

Showing results (31-40 of 505) with videos related to

Sort By:
Pageof 51
Journal of Cancer Research and Clinical Oncology|January 31, 2018
Patients' and hematologists' concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemiaQian Jiang, Lu Yu, Robert Peter Gale
Mediterranean Journal of Hematology and Infectious Diseases|May 19, 2021
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple MyelomaMonia Marchetti, Robert Peter Gale, Giovanni Barosi
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|March 8, 2022
The application of arterio-venous ratio (AVR) cut-off values in clinic to stratify cardiovascular risk in patientsChristian French, Robert Peter Cubbidge, Rebekka Heitmar
Acta Haematologica|July 24, 2025
Beyond CAR-T: The Rise of CAR-NK/T Cells for Haematological CancerMohammadamin Noorafrooz, Robert Peter Gale, Mohadese Dashtkoohi
Bone Marrow Transplantation|February 25, 2018
The big freeze may be over: a contracting universe for cryopreservation?Robert Peter Gale, Guillermo J Ruiz-Argüelles
Leukemia Research|January 18, 2003
Modeling minimal residual disease (MRD)-testingAnna Butturini, John Klein, Robert Peter Gale
Journal of Clinical Medicine|July 2, 2021
Will New Drugs Replace Transplants for Chronic Lymphocytic Leukaemia?Shenmiao Yang, Xiaojun Huang, Robert Peter Gale
Journal of Hematology & Oncology|December 16, 2014
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemiaBing Li, Robert Peter Gale, Zhijian Xiao
Leukemia|March 4, 2023
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectivesGiovanni Barosi, Vittorio Rosti, Robert Peter Gale
Journal of Nanoscience and Nanotechnology|May 5, 2015
Synthesis and characterization of alkyl ester functionalized multiwall carbon nanotubesFabio Faraguna, Robert Peter, Vesna Volovšek, et al.
Pageof 51